Premium
Multimedia Journalist·Bay of Plenty Times·
12 Nov, 2026 05:00 PM5 mins to read
Pāpāmoa mother Heather Johnson was diagnosed with Stage 3 breast cancer in 2021 before it progressed to terminal Stage 4 in 2024. Photo / Kelly O'Hara
A mother with terminal breast cancer believes a drug funded publicly only for late-stage patients could have delayed the progression of the disease if she had been eligible earlier.
Heather Johnson says her “high-risk”, Stage 3 breast cancer diagnosis in 2021 meant her chance of surviving for 10 years was
Source: New Zealand Herald · Megan Wilson
At a glance
- Topic
- Health
- Country
- 🇳🇿 NZ
- Publisher language
- EN
- Added to Allnira